Further, we observed BC-1901S activated NRF2 through KEAP1-independent pathway, and through RNAi screening we uncovered the ubiquitin E3 ligase DDB1 and CUL4 Associated Factor 1 (DCAF1) as a non-canonical regulator of NRF2 stability. Here, NFE2L2 is linked to breast cancer.